Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio

Episode 28 February 23, 2023 00:30:48
Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio

Feb 23 2023 | 00:30:48

/

Show Notes

“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other families who have sick kids is that we all have a tremendous amount of hope that a potential treatment will come to the forefront for our child.” – Dr. Alok Tayi, Founder and CEO of Vibe Bio

Biorasi welcomes Dr. Alok Tayi to the Few & Far Between podcast to explore the power and determination that patients have when it comes to finding a treatment for rare disease. 

Other Episodes

Episode 33

September 20, 2023 00:26:33
Episode Cover

Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals

Listen

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 5

July 07, 2021 00:51:14
Episode Cover

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...

Listen